Joint swelling
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
33
|
|
0.100 |
None |
|
0 |
|
|
|
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
31
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
PROSTATE CANCER, SOMATIC
|
disease |
|
Neoplastic Process
|
6
|
18
|
0.100 |
None |
|
0 |
2
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.100 |
None |
|
0 |
1
|
|
|
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
|
0 |
2
|
|
|
Serum alkaline phosphatase raised
|
phenotype |
|
Finding
|
67
|
6
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the tibial metaphysis
|
disease |
|
Anatomical Abnormality
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the femoral metaphysis
|
disease |
|
Anatomical Abnormality
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the fallopian tube
|
phenotype |
|
Anatomical Abnormality
|
22
|
|
0.100 |
None |
|
0 |
|
|
|
Fibrofolliculoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
10
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Increased lactate dehydrogenase activity
|
phenotype |
|
Finding
|
27
|
|
0.100 |
None |
|
0 |
|
|
|
Hematochezia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
37
|
12
|
0.100 |
None |
|
0 |
1
|
|
|
Pathological fracture
|
phenotype |
Wounds and Injuries
|
Pathologic Function
|
35
|
2
|
0.100 |
None |
|
0 |
|
|
|
Weight decreased
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
271
|
3
|
0.100 |
None |
|
0 |
|
|
|
Neoplasm of uncertain or unknown behavior of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
PROSTATE CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
4
|
|
|
Alkaline phosphatase raised
|
phenotype |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Finding
|
55
|
|
0.100 |
None |
|
0 |
|
|
|
Progressive encephalopathy
|
phenotype |
Nervous System Diseases
|
Finding
|
14
|
5
|
0.100 |
None |
|
0 |
|
|
|
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
7
|
0.100 |
None |
|
0 |
7
|
|
|
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
3
|
8
|
0.100 |
None |
|
0 |
1
|
|
|
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Primary peritoneal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
49
|
|
0.100 |
None |
|
0 |
|
|
|